INS and type 2 diabetes mellitus: This dysbiotic shift weakens gut barrier integrity, increasing gut permeability and LPS translocation, which causes metabolic endotoxemia, intensifies chronic inflammation, reduces SCFA production, and disrupts insulin signaling, exacerbating T2D complications [60].